Andrei_Fodor

I thank Estro for the opportunity to present the preliminary results of the PRO-FAST trial, one of the few in the world of single-fraction prostate radiotherapy . Convenient for patients, the entire procedure is completed in one day, with low toxicity and excellent PSA control.

📢The PRO-FAST trial is a novel 1-day, single-fx #prostatecancer tx w/ #CyberKnife 👏 📆Sat 17:30 poster area Dr Sara Broggi physics 🔗online.flippingbook.com/view/701322381… 📆Sun 9am T2 @DrAndreiFodor 1-year cum tox 🔗 online.flippingbook.com/view/701322381… #ESTRO26 @ESTRO_RT

ZERO cases of cervical cancer diagnosed in women under age 25 in Australia 🇦🇺 None . Nada . Zip. For the first time since records began! How did this happen? One word VACCINES!!!!!

In localized radiorecurrent #ProstateCancer, salvage focal therapy provided similar 10-year survival outcomes as radical prostatectomy but resulted in substantially fewer perioperative complications. ja.ma/4rbkdTR

🙏 Huge credit to all speakers, moderators and colleagues who made the 1️⃣#prostateSBRTMonza 🇮🇹Symposium a great success🤩 #ProstateCancer @ESTRO_RT @ISRSy @airo_young

1/ Thank you 🙏🏾, patients, families, and investigators, for contributing to the SEISMIC 🫁trial out now @LancetRespirMed - shorturl.at/qxMUY. Led by 🫁@DanSteinfort, this international multicentre recruited n=155 trial from 🇦🇺, 🇨🇦, 🇺🇸, 🇳🇱 #radonc @tssmn @PeterMacRadOnc

❓ What is the optimal duration of ADT if combined with EBRT for definitive treatment of prostate cancer Virtual Grand Rounds in Radiation Oncology 🎙 Speaker: Dr. @NicholasZaorsky 📅 February 4th, 5 - 5.30 pm CET 💻 Join us virtually here: 👇 usz.ch/en/events/virt…

Reparto Radioterapia AOzu Sant’Andrea Università Sapienza Roma

🧨 Join us for #PCa #SBRT Symposium by @StAr_MCM74 & @PanizzaDenis with 🔝tier international faculty @piet_ost @CDraulans @CZamboglou and 🌟Italian RadOncs together with @ESTRO_RT President @BarbaraJereczek 🔗Registrations open—limited seats tinyurl.com/sbrt2026 @valefacc22

Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer: A Practical Multidisciplinary Approach to Challenging Scenarios from the IASLC Advanced Radiation Technology (ART) Subcommittee - Journal of Thoracic Oncology jto.org/article/S1556-…

🚀 Early data from the #STARRtrial (NCT05455736) show promising results for SSRT in macroscopic prostate bed recurrence post-prostatectomy—without ADT! 📉 82.6% complete biochemical response ✅ Mild toxicity ⚡️ Fast, focused, and well-tolerated #EMUC2025 @NiccolBertini2

#SABR2025 SABR for oligoprogressive disease: when and how?

@_ShankarSiva @MD_Ela2012 @ASTRO_org @gerryhanna @Mat_Guc @SbrtSean @piet_ost @DrewMoghanaki @jryckman3 @ndesai2005 @AmarUKishan @DrMHofman @drlouiseemmett Only 7 mo in the SBRT arm in HSPC? Similar to control arms in MDT trials…Usually are at least double.

🔥 LUNAR trial: In oligometastatic hormone-sensitive #ProstateCancer, adding 2 cycles of 177Lu-PSMA 💥 ☢️ before SBRT ⬆️ doubled PFS (18 vs 7 mo, HR 0.32, p<0.001) with minimal added adverse events. 🚀 PSMA-RLT + SBRT = new frontier #ASTRO25 #RadOnc #NuclearMedicine @ASTRO_org

#astro25 @NRGonc Rtog 0924 trial on 2500 patients testing whole pelvic RT. Negative trial -OS no difference -PCSM no difference -DM no difference -BCR was not SS different with only 4% difference at 10 years. -toxicity increased 3 cooperative group trials now negative: getug01, Rtog 9413, Rtog 0924. Goodbye WPRT

Really Happy to present early results of PERSIAN trial at ASTRO 2025! #ASTRO @dicataldovanes1 @PietroGarlatti

Two-year clinical outcomes following ablative radiotherapy for unfavorable prostate tumors (ABRUPT). Presented by @StAr_MCM74 @unimib. #ASTRO25 written coverage by @RKSayyid @UAUrology > bit.ly/3IKjvfj @ASTRO_org

Quelli di @dissapore barano giocando con le parole e mettono in pericolo la salute delle persone più vulnerabili. Non può essere concesso.

Short-term cardioprotection with bisoprolol/ramipril significantly reduces right ventricular dysfunction in #breastcancer patients receiving #anthracyclines (SAFE trial substudy) 🫀 RV CTRCD at 24 months: 📉 49.2% placebo vs 22% @escardio @OncoAlert onlinelibrary.wiley.com/doi/10.1111/ec…

La ricerca più avanzata dà nuova vita a vecchi farmaci. L'aspirina dimezza la recidiva di alcuni tipi di cancro al colon-retto. Alla faccia di Big Pharma. burioni.substack.com

Nearly 30 years, 100 H Index —career path in oncology comes with sacrifices, setbacks, and the strength to rise again. My journey began at Columbia in the ‘90s, studying bladder cancer and DNA adducts. Keep pushing through the challenges! @myESMO @LaStatale @IEOufficiale